|
1
|
Doroszewska K, Milewicz T, Mrozińska S,
Janeczko J, Rokicki R, Janeczko M, Warzecha D and Marianowski P:
Blood pressure in postmenopausal women with a history of polycystic
ovary syndrome. Prz Menopauzalny. 18:94–98. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Seyam E, Al Gelany S, Abd Al Ghaney A,
Mohamed MAA, Youseff AM, Ibrahim EM, Khalifa EM and Hefzy E:
Evaluation of prolonged use of statins on the clinical and
biochemical abnormalities and ovulation dysfunction in single young
women with polycystic ovary syndrome. Gynecolo Endocrinol.
34:589–596. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sharma S, Mathur DK, Paliwal V and
Bhargava P: Efficacy of metformin in the treatment of acne in women
with polycystic ovarian syndrome: A newer approach to acne therapy.
J Clin Aes DermatO. 12:34–38. 2019.PubMed/NCBI
|
|
4
|
Moini Jazani A, Nasimi Doost Azgomi H,
Nasimi Doost Azgomi A and Nasimi Doost Azgomi R: A comprehensive
review of clinical studies with herbal medicine on polycystic ovary
syndrome (PCOS). Daru. 27:863–877. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kriedt KJ, Alchami A and Davies MC: PCOS:
Diagnosis and management of related infertility. Obstet Gynaecol
Reprod Med. 29:1–5. 2019.
|
|
6
|
Arentz S, Abbott JA, Smith CA and
Bensoussan A: Herbal medicine for the management of polycystic
ovary syndrome (PCOS) and associated oligo/amenorrhoea and
hyperandrogenism; a review of the laboratory evidence for effects
with corroborative clinical findings. BMC Complement Altern Med.
14(511)2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yu YS, Sui HS, Han ZB, Li W, Luo MJ and
Tan JH: Apoptosis in granulosa cells during follicular atresia:
Relationship with steroids and insulin-like growth factors. Cell
Res. 14:341–346. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Niu Z, Ye Y, Xia L, Feng Y and Zhang A:
Follicular fluid cytokine composition and oocyte quality of
polycystic ovary syndrome patients with metabolic syndrome
undergoing in vitro fertilization. Cytokine. 91:180–186.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Salei N, Hellberg L, Köhl J and Laskay T:
Enhanced survival of Leishmania major in neutrophil
granulocytes in the presence of apoptotic cells. PLoS One.
12(e0171850)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xiang Y, Song Y, Li Y, Zhao D, Ma L and
Tan L: miR-483 is down-regulated in polycystic ovarian syndrome and
inhibits KGN cell proliferation via targeting insulin-like growth
factor 1 (IGF1). Med Sci Monit. 22:3383–3393. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sun L, Zuo Z, Luo H, Chen M, Zhong Y, Chen
Y and Wang C: Chronic exposure to phenanthrene influences the
spermatogenesis of male sebastiscus marmoratus: U-shaped
effects and the reason for them. Environ Sci Technol.
45:10212–10218. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ibáñez L, Oberfield SE, Witchel S, Auchus
RJ, Chang RJ, Codner E, Dabadghao P, Darendeliler F, Elbarbary NS,
Gambineri A, et al: An international consortium update:
Pathophysiology, diagnosis, and treatment of polycystic ovarian
syndrome in adolescence. Horm Res Paediatr. 88:371–395.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Díaz M, Bassols J, López-Bermejo A, de
Zegher F and Ibáñez L: Low circulating levels of miR-451a in girls
with polycystic ovary syndrome: Different effects of randomized
treatments. J Clin Endocri Metabo. 105(dgz204)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sun X, Su S, Zhang G, Zhang H and Yu X:
MiR-204 suppresses cell proliferation and promotes apoptosis in
ovarian granulosa cells via targeting TPT1 in polycystic ovary
syndrome. Biochem Cell Biol. 97:554–562. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
He T, Sun Y, Zhang Y, Zhao S, Zheng Y, Hao
G and Shi Y: MicroRNA-200b and microRNA-200c are up-regulated in
PCOS granulosa cell and inhibit KGN cell proliferation via
targeting PTEN. Reprod Biol Endocrinol. 17(68)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li Y, Liu YD, Zhou XY, Chen SL, Chen X,
Zhe J, Zhang J, Zhang QY and Chen YX: MiR-29a regulates the
proliferation, aromatase expression, and estradiol biosynthesis of
human granulosa cells in polycystic ovary syndrome. Mol Cell
Endocrinol. 498(110540)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Minna E, Romeo P, Dugo M, De Cecco L,
Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, et
al: miR-451a is underexpressed and targets AKT/mTOR pathway in
papillary thyroid carcinoma. Oncotarget. 7:12731–12747.
2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shen YY, Cui JY, Yuan J and Wang X:
MiR-451a suppressed cell migration and invasion in non-small cell
lung cancer through targeting ATF2. Eur Rev Med Pharmacol Sci.
22:5554–5561. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhao S, Li J, Zhang G, Wang Q, Wu C, Zhang
Q, Wang H, Sun P, Xiang R and Yang S: Exosomal miR-451a functions
as a tumor suppressor in hepatocellular carcinoma by targeting
LPIN1. Cell Physiol Biochem. 53:19–35. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu K, Han B, Bai Y, Ma XY, Ji ZN, Xiong Y,
Miao SK, Zhang YY and Zhou LM: MiR-451a suppressing BAP31 can
inhibit proliferation and increase apoptosis through inducing ER
stress in colorectal cancer. Cell Death Dis. 10(152)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wei GY, Hu M, Zhao L and Guo WS: MiR-451a
suppresses cell proliferation, metastasis and EMT via targeting
YWHAZ in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci.
23:5158–5167. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li M, Song Q, Li H, Lou Y and Wang L:
Circulating miR-25-3p and miR-451a may be potential biomarkers for
the diagnosis of papillary thyroid carcinoma. PLoS One.
10(e0132403)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Watson G, Ronai ZA and Lau E: ATF2, a
paradigm of the multifaceted regulation of transcription factors in
biology and disease. Pharmacol Res. 119:347–357. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dai Y, Zang Y, Li J, Liu Y and Wan B:
miR-181a and miR-203 inhibit migration and invasion of laryngeal
carcinoma cells by interacting with ATF2. Int J Clin Exp Pathol.
12:133–141. 2019.PubMed/NCBI
|
|
26
|
Li Q, Gao WQ, Dai WY, Yu C, Zhu RY and Jin
J: ATF2 translation is induced under chemotherapeutic drug-mediated
cellular stress via an IRES-dependent mechanism in human hepatic
cancer Bel7402 cells. Oncol Lett. 12:4795–4802. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yivgi-Ohana N, Sher N, Melamed-Book N,
Eimerl S, Koler M, Manna PR, Stocco DM and Orly J: Transcription of
steroidogenic acute regulatory protein in the rodent ovary and
placenta: Alternative modes of cyclic adenosine 3',
5'-monophosphate dependent and independent regulation.
Endocrinology. 150:977–989. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Riaz H, Liang A, Khan MK, Dong P, Han L,
Shahzad M, Chong Z, Ahmad S, Hua G and Yang L: Somatostatin and its
receptors: Functional regulation in the development of mice Sertoli
cells. J Steroid Biochem Mol Biol. 138:257–266. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Han L, Wu C, Riaz H, Bai L, Chen J, Zhen
Y, Guo A and Yang L: Characterization of the mechanism of inhibin
α-subunit gene in mouse anterior pituitary cells by RNA
interference. PLoS One. 8(e74596)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhen YH, Wang L, Riaz H, Wu JB, Yuan YF,
Han L, Wang YL, Zhao Y, Dan Y and Huo LJ: Knockdown of CEBPβ by
RNAi in porcine granulosa cells resulted in S phase cell cycle
arrest and decreased progesterone and estradiol synthesis. J
Steroid Biochem Mol Biol. 143:90–98. 2014.PubMed/NCBI View Article : Google Scholar
|
